144 related articles for article (PubMed ID: 19116239)
1. Study of circulating prohepcidin in association with insulin sensitivity and changing iron stores.
Fernández-Real JM; Equitani F; Moreno JM; Manco M; Ortega F; Ricart W
J Clin Endocrinol Metab; 2009 Mar; 94(3):982-8. PubMed ID: 19116239
[TBL] [Abstract][Full Text] [Related]
2. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
[TBL] [Abstract][Full Text] [Related]
3. Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women.
Huang X; Fung ET; Yip C; Zeleniuch-Jacquotte A
Blood Cells Mol Dis; 2008; 41(3):265-9. PubMed ID: 18694648
[TBL] [Abstract][Full Text] [Related]
4. Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease.
Lee SH; Jeong SH; Park YS; Hwang JH; Kim JW; Kim N; Lee DH
Korean J Hepatol; 2010 Sep; 16(3):288-94. PubMed ID: 20924211
[TBL] [Abstract][Full Text] [Related]
5. Iron absorption by healthy women is not associated with either serum or urinary prohepcidin.
Hadley KB; Johnson LK; Hunt JR
Am J Clin Nutr; 2006 Jul; 84(1):150-5. PubMed ID: 16825689
[TBL] [Abstract][Full Text] [Related]
6. Prohepcidin and iron metabolism parameters in the obese elderly patients with anemia.
Przybyszewska J; Zekanowska E; Kedziora-Kornatowska K; Boinska J; Cichon R; Porzych K
J Nutr Health Aging; 2011 Apr; 15(4):259-64. PubMed ID: 21437556
[TBL] [Abstract][Full Text] [Related]
7. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
[TBL] [Abstract][Full Text] [Related]
8. Does hepcidin affect erythropoiesis in hemodialysis patients?
Eleftheriadis T; Kartsios C; Liakopoulos V; Antoniadi G; Ditsa M; Papadopoulos C; Anifandis G; Skirta A; Markala D; Stefanidis I
Acta Haematol; 2006; 116(4):238-44. PubMed ID: 17119323
[TBL] [Abstract][Full Text] [Related]
9. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
[TBL] [Abstract][Full Text] [Related]
10. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
[TBL] [Abstract][Full Text] [Related]
11. Serum prohepcidin concentrations in rheumatoid arthritis.
Jayaranee S; Sthaneshwar P; Sokkalingam S
Pathology; 2009 Feb; 41(2):178-82. PubMed ID: 18972320
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum prohepcidin concentration in patients with polycythemia vera.
Kwapisz J; Zekanowska E; Jasiniewska J
J Zhejiang Univ Sci B; 2009 Nov; 10(11):791-5. PubMed ID: 19882752
[TBL] [Abstract][Full Text] [Related]
13. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
[TBL] [Abstract][Full Text] [Related]
14. Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C.
Caliskan Y; Yelken B; Ozkok A; Gorgulu N; Yazici H; Telci A; Yildiz A
BMC Nephrol; 2012 Jul; 13():56. PubMed ID: 22768976
[TBL] [Abstract][Full Text] [Related]
15. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
[TBL] [Abstract][Full Text] [Related]
16. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of and correspondence among different hepcidin forms in blood and urine and their relationships to iron status in healthy, male Guatemalan volunteers observed over 9 weeks.
Schuemann K; Solomons NW; Laarakkers CM; Romero-Abal ME; Kroll S; Weiss G; Swinkels DW
Ann Nutr Metab; 2011; 58(2):158-66. PubMed ID: 21654163
[TBL] [Abstract][Full Text] [Related]
18. [Serum prohepcidin and other iron metabolism parameters in healthy adults].
Zekanowska E; Boinska J; Kwapisz J; Kedziora-Kornatowska K; Porzych K; Ratajczak M
Przegl Lek; 2011; 68(2):82-6. PubMed ID: 21751515
[TBL] [Abstract][Full Text] [Related]
19. Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes.
Aso Y; Takebayashi K; Wakabayashi S; Momobayashi A; Sugawara N; Terasawa T; Naruse R; Hara K; Suetsugu M; Morita K; Inukai T
Diabetes Res Clin Pract; 2010 Dec; 90(3):250-5. PubMed ID: 20888657
[TBL] [Abstract][Full Text] [Related]
20. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.
Girelli D; Trombini P; Busti F; Campostrini N; Sandri M; Pelucchi S; Westerman M; Ganz T; Nemeth E; Piperno A; Camaschella C
Haematologica; 2011 Apr; 96(4):500-6. PubMed ID: 21173098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
